Current Diabetes Reports

, Volume 11, Issue 2, pp 99–105 | Cite as

Inpatient Enteral and Parental Nutrition for Patients with Diabetes



Both glycemic control and adequate nutrition support impact the clinical outcome of hospitalized patients. Providing nutrition to malnourished patients using the enteral or parenteral route may increase the risk of hyperglycemia, especially in patients with diabetes. Hyperglycemia can be managed through the use of enteral tube feeds with reduced carbohydrate content or limiting the carbohydrate concentration in parenteral formulas. Judicious use of insulin or other glucose-lowering medications synchronized with appropriate nutrition support allows for optimal inpatient glycemic control.


Diabetes Enteral nutrition Parenteral nutrition Hospitalized patients 



Conflicts of interest: M. Via: none; J. Mechanick: has received speaker honoraria from and serves on an Advisory Board on diabetes and nutrition for Abbott Nutrition.


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    (2008) Economic costs of diabetes in the U.S. In 2007. Diabetes Care 31:596–615.Google Scholar
  2. 2.
    Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE (2009) American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 15:353–369.PubMedCrossRefGoogle Scholar
  3. 3.
    Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus. J Manag Care Pharm 16:264–275.Google Scholar
  4. 4.
    Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F (2007) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 13 Suppl 1:1–68.PubMedGoogle Scholar
  5. 5.
    Braithwaite SS (2008) Inpatient insulin therapy. Curr Opin Endocrinol Diabetes Obes 15:159–166.PubMedCrossRefGoogle Scholar
  6. 6.
    Moghissi ES (2010) Reexamining the evidence for inpatient glucose control: new recommendations for glycemic targets. Am J Health Syst Pharm 67:S3–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Furnary AP, Zerr KJ, Grunkemeier GL, Starr A (1999) Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67:352–360; discussion 360–352.PubMedCrossRefGoogle Scholar
  8. 8.
    Investigators TN-SS (2009) Intensive versus Conventional Glucose Control in Critically Ill Patients. New England Journal of Medicine 360:1283–1297.CrossRefGoogle Scholar
  9. 9.
    van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367.PubMedCrossRefGoogle Scholar
  10. 10.
    Krinsley JS (2008) Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 36:3008–3013.PubMedCrossRefGoogle Scholar
  11. 11.
    • McClave SA, Martindale RG, Vanek VW, McCarthy M, Roberts P, Taylor B, Ochoa JB, Napolitano L, Cresci G (2009) Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 33:277–316. This is the American Society of Parenteral and Enteral Nutrition most currently released guidelines for nutritional support in inpatients.PubMedCrossRefGoogle Scholar
  12. 12.
    Dvir D, Cohen J, Singer P (2006) Computerized energy balance and complications in critically ill patients: an observational study. Clin Nutr 25:37–44.PubMedCrossRefGoogle Scholar
  13. 13.
    Villet S, Chiolero RL, Bollmann MD, Revelly JP, Cayeux RNM, Delarue J, Berger MM (2005) Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr 24:502–509.PubMedCrossRefGoogle Scholar
  14. 14.
    Bankhead R, Boullata J, Brantley S, Corkins M, Guenter P, Krenitsky J, Lyman B, Metheny NA, Mueller C, Robbins S, Wessel J (2009) Enteral nutrition practice recommendations. JPEN J Parenter Enteral Nutr 33:122–167.PubMedCrossRefGoogle Scholar
  15. 15.
    Standards of medical care in diabetes—2010. Diabetes Care 33 Suppl 1:S11–61.Google Scholar
  16. 16.
    Sheard NF, Clark NG, Brand-Miller JC, Franz MJ, Pi-Sunyer FX, Mayer-Davis E, Kulkarni K, Geil P (2004) Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the american diabetes association. Diabetes Care 27:2266–2271.PubMedCrossRefGoogle Scholar
  17. 17.
    Cereda E, Pedrolli C (2009) Way of delivering food in hospital to improve nutrition. Clin Nutr 28:105; author reply 106.PubMedCrossRefGoogle Scholar
  18. 18.
    Kaidar-Person O, Person B, Szomstein S, Rosenthal RJ (2008) Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? Part A: vitamins. Obes Surg 18:870–876.PubMedCrossRefGoogle Scholar
  19. 19.
    Mechanick JI, Brett EM (2005) Nutrition and the chronically critically ill patient. Curr Opin Clin Nutr Metab Care 8:33–39.PubMedCrossRefGoogle Scholar
  20. 20.
    Lochs H, Allison SP, Meier R, Pirlich M, Kondrup J, Schneider S, van den Berghe G, Pichard C (2006) Introductory to the ESPEN Guidelines on Enteral Nutrition: Terminology, definitions and general topics. Clin Nutr 25:180–186.PubMedCrossRefGoogle Scholar
  21. 21.
    Krishnan JA, Parce PB, Martinez A, Diette GB, Brower RG (2003) Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest 124:297–305.PubMedCrossRefGoogle Scholar
  22. 22.
    Robertson L, Waugh N, Robertson A (2007) Protein restriction for diabetic renal disease. Cochrane Database Syst Rev CD002181.Google Scholar
  23. 23.
    Port AM, Apovian C (2010) Metabolic support of the obese intensive care unit patient: a current perspective. Curr Opin Clin Nutr Metab Care 13:184–191.PubMedCrossRefGoogle Scholar
  24. 24.
    Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ (2005) Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care 28:2267–2279.PubMedCrossRefGoogle Scholar
  25. 25.
    Kim HS, Paik HY, Lee KU, Lee HK, Min HK (1988) Effects of several simple sugars on serum glucose and serum fructose levels in normal and diabetic subjects. Diabetes Res Clin Pract 4:281–287.PubMedCrossRefGoogle Scholar
  26. 26.
    Hofman Z, van Drunen JD, de Later C, Kuipers H (2004) The effect of different nutritional feeds on the postprandial glucose response in healthy volunteers and patients with type II diabetes. Eur J Clin Nutr 58:1553–1556.PubMedCrossRefGoogle Scholar
  27. 27.
    Sturmer W, Kramer E, Kasper H, Schrezenmeir J (1994) Favourable glycaemic effects of a new balanced liquid diet for enteral nutrition—Results of a short-term study in 30 type II diabetic patients. Clin Nutr 13:221–227.PubMedCrossRefGoogle Scholar
  28. 28.
    Thomas BL, Laine DC, Goetz FC (1988) Glucose and insulin response in diabetic subjects: acute effect of carbohydrate level and the addition of soy polysaccharide in defined-formula diets. Am J Clin Nutr 48:1048–1052.PubMedGoogle Scholar
  29. 29.
    Voss AC, Maki KC, Garvey WT, Hustead DS, Alish C, Fix B, Mustad VA (2008) Effect of two carbohydrate-modified tube-feeding formulas on metabolic responses in patients with type 2 diabetes. Nutrition 24:990–997.PubMedCrossRefGoogle Scholar
  30. 30.
    Craig LD, Nicholson S, SilVerstone FA, Kennedy RD (1998) Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition 14:529–534.PubMedCrossRefGoogle Scholar
  31. 31.
    McCargar LJ, Innis SM, Bowron E, Leichter J, Dawson K, Toth E, Wall K (1998) Effect of enteral nutritional products differing in carbohydrate and fat on indices of carbohydrate and lipid metabolism in patients with NIDDM. Mol Cell Biochem 188:81–89.PubMedCrossRefGoogle Scholar
  32. 32.
    Mesejo A, Acosta JA, Ortega C, Vila J, Fernandez M, Ferreres J, Sanchis JC, Lopez F (2003) Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients. Clin Nutr 22:295–305.PubMedCrossRefGoogle Scholar
  33. 33.
    Pohl M, Mayr P, Mertl-Roetzer M, Lauster F, Lerch M, Eriksen J, Haslbeck M, Rahlfs VW (2005) Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomised controlled trial. Eur J Clin Nutr 59:1221–1232.PubMedCrossRefGoogle Scholar
  34. 34.
    del Carmen Crespillo M, Olveira G, de Adana MS, Rojo-Martinez G, Garcia-Aleman J, Olvera P, Soriguer F, Munoz A (2003) Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. Clin Nutr 22:483–487.CrossRefGoogle Scholar
  35. 35.
    Peters AL, Davidson MB (1992) Effects of various enteral feeding products on postprandial blood glucose response in patients with type I diabetes. JPEN J Parenter Enteral Nutr 16:69–74.PubMedCrossRefGoogle Scholar
  36. 36.
    Peters AL, Davidson MB, Isaac RM (1989) Lack of glucose elevation after simulated tube feeding with a low-carbohydrate, high-fat enteral formula in patients with type I diabetes. Am J Med 87:178–182.PubMedCrossRefGoogle Scholar
  37. 37.
    Gul A, Rahman MA, Hasnain SN (2009) Influence of fructose concentration on myocardial infarction in senile diabetic and non-diabetic patients. Exp Clin Endocrinol Diabetes 117:605–609.PubMedCrossRefGoogle Scholar
  38. 38.
    Tappy L, Le KA, Tran C, Paquot N (2010) Fructose and metabolic diseases: New findings, new questions. Nutrition.Google Scholar
  39. 39.
    Scurlock C, Raikhelkar J, Mechanick JI (2010) Critique of normoglycemia in intensive care evaluation: survival using glucose algorithm regulation (NICE-SUGAR)—a review of recent literature. Curr Opin Clin Nutr Metab Care 13:211–214.PubMedCrossRefGoogle Scholar
  40. 40.
    Via MA, Scurlock C, Adams DH, Weiss AJ, Mechanick JI (2010) An Impaired Postoperative Hyperglycemic Stress Response is Associated with Increased Mortality in Cardiothoracic Surgery Patients. Endocr Pract 16:798–804.PubMedCrossRefGoogle Scholar
  41. 41.
    • Ziegler TR (2009) Parenteral nutrition in the critically ill patient. N Engl J Med 361:1088–1097. This is a recent review article describing current state-of-the-art practices for the use of PN based on all available evidence.PubMedCrossRefGoogle Scholar
  42. 42.
    Lin LY, Lin HC, Lee PC, Ma WY, Lin HD (2007) Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci 333:261–265.PubMedCrossRefGoogle Scholar
  43. 43.
    Pasquel FJ, Spiegelman R, McCauley M, Smiley D, Umpierrez D, Johnson R, Rhee M, Gatcliffe C, Lin E, Umpierrez E, Peng L, Umpierrez GE (2010) Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care 33:739–741.PubMedCrossRefGoogle Scholar
  44. 44.
    Mechanick JI (1996) Parenteral nutrition formulation: an integral part of the endocrinologist’s metabolic support consultation service. Endocr Pract 2:197–203.PubMedGoogle Scholar
  45. 45.
    Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267–2277.PubMedCrossRefGoogle Scholar
  46. 46.
    Hoeg LD, Sjoberg KA, Jeppesen J, Jensen TE, Frosig C, Birk JB, Bisiani B, Hiscock N, Pilegaard H, Wojtaszewski JF, Richter EA, Kiens B (2010) Lipid induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling. Diabetes.Google Scholar
  47. 47.
    Liu Z, Liu J, Jahn LA, Fowler DE, Barrett EJ (2009) Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. J Clin Endocrinol Metab 94:3543–3549.PubMedCrossRefGoogle Scholar
  48. 48.
    Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A (1977) Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30:531–538.PubMedGoogle Scholar
  49. 49.
    Via M, Scurlock C, Raikhelkar J, Di Luozzo G, Mechanick JI (2008) Chromium infusion reverses extreme insulin resistance in a cardiothoracic ICU patient. Nutr Clin Pract 23:325–328.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of Endocrinology and Metabolism, Beth Israel Medical CenterAlbert Einstein College of MedicineNew YorkUSA
  2. 2.Metabolic Support, Division of Endocrinology, Diabetes, and Bone DiseaseMount Sinai School of MedicineNew YorkUSA

Personalised recommendations